A Canadian cohort with the IVS10+14 MAPT mutation

enthalten in: Alzheimer's & Dementia | 2021

von Maxwell, S. | Cash, M. | Rockwood, K. | +2

P2‐157 : CHOLINERGIC NEURONS IN NUCLEUS SUBPUTAMINALIS IN PRIMARY PROGRESSIVE APHASIA

enthalten in: Alzheimer's & Dementia | 2019

von Hamodat, H. | Fisk, J. | Darvesh, S.

IC‐P‐065 : BUTYRYLCHOLINESTERASE GENETIC POLYMORPHISM AND NEUROIMAGING BIOMARKERS IN ALZHEIMER'S DISEASE

enthalten in: Alzheimer's & Dementia | 2018

von DeBay, D. | Maxwell, S. | Luke, D. | +6

P1‐424 : BUTYRYLCHOLINESTERASE GENETIC POLYMORPHISM AND NEUROIMAGING BIOMARKERS IN ALZHEIMER'S DISEASE

enthalten in: Alzheimer's & Dementia | 2018

von DeBay, D. | Maxwell, S. | Luke, D. | +6

Disclosure of the diagnosis of dementia

enthalten in: Alzheimer's & Dementia | 2007

von Fisk, J. | Beattie, B. | Donnelly, M. | +2

Neuropsychological testing and assessment for dementia

enthalten in: Alzheimer's & Dementia | 2007

von Jacova, C. | Kertesz, A. | Blair, M. | +2

Ethical considerations for decision making for treatment and research participation

enthalten in: Alzheimer's & Dementia | 2007

von Fisk, J. | Beattie, B. | Donnelly, M.